ID dell’articolo ATH-53YKM9 · Tier 2 papers · Inorganic chemistry

An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals CC-BY

Opera in accesso aperto archiviata, importata da Beilstein Journal of Organic Chemistry per la conservazione a lungo termine. Non è un invio ad AthenXiv, quindi non ha cronologia delle versioni né cronologia delle marche temporali.

  • Pubblicato originariamente Apr 18, 2011 UTC
  • Diritti: CC-BY (nessuna data di scadenza registrata)
  • Aggiunto ad AthenXiv Oct 3, 2026 UTC
  • Marcus Baumann University of Cambridge
  • Ian R. Baxendale University of Cambridge
  • Steven V. Ley University of Cambridge
  • Nikzad Nikbin University of Cambridge

Inviato da AthenXiv UW2JTS24Y · Pubblicato Oct 3, 2026 UTC · 708 Visualizzazioni · 23 Download · 3.6 MB · English

Caricato per conto dell’autore da AthenXiv (UW2JTS24Y)

Leggi online Scarica il PDF (3.6 MB)

Sommario

This review presents a comprehensive overview on selected synthetic routes towards commercial drug compounds as published in both journal and patent literature. Owing to the vast number of potential structures, we have concentrated only on those drugs containing five-membered heterocycles and focused principally on the assembly of the heterocyclic core. In order to target the most representative chemical entities the examples discussed have been selected from the top 200 best selling drugs of recent years.

Parole chiave: Synthesis and Catalytic Reactions, Organic Chemistry, Chemistry, Physical Sciences

DOI: 10.3762/bjoc.7.57

Licenza: CC-BY

Leggi online

Cita questo articolo

BibTeX RIS Testo semplice JSON

Marcus Baumann, Ian R. Baxendale, Steven V. Ley, Nikzad Nikbin (2026). An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals. AthenXiv. https://athenxiv.com/paper/ATH-53YKM9